Heart Failure 1 In search of new therapeutic targets and strategies for heart failure: recent advances in basic science

被引:220
作者
Shah, Ajay M. [1 ]
Mann, Douglas L. [2 ]
机构
[1] Kings Coll London, British Heart Fdn, Ctr Excellence, London SE5 9NU, England
[2] Washington Univ, Sch Med, St Louis, MO USA
关键词
MITOCHONDRIAL PERMEABILITY TRANSITION; CARDIAC-HYPERTROPHY; SYSTEMS BIOLOGY; MYOCARDIAL-INFARCTION; ENERGY-METABOLISM; CA2+; CARDIOMYOCYTES; CONTRIBUTES; EXPRESSION; AUTOPHAGY;
D O I
10.1016/S0140-6736(11)60894-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic heart failure continues to impose a substantial health-care burden, despite recent treatment advances. The key pathophysiological process that ultimately leads to chronic heart failure is cardiac remodelling in response to chronic disease stresses. Here, we review recent advances in our understanding of molecular and cellular mechanisms that play a part in the complex remodelling process, with a focus on key molecules and pathways that might be suitable targets for therapeutic manipulation. Such pathways include those that regulate cardiac myocyte hypertrophy, calcium homoeostasis, energetics, and cell survival, and processes that take place outside the cardiac myocyte-eg, in the myocardial vasculature and extracellular matrix. We also discuss major gaps in our current understanding, take a critical look at conventional approaches to target discovery that have been used to date, and consider new investigational avenues that might accelerate clinically relevant discovery.
引用
收藏
页码:704 / 712
页数:9
相关论文
共 84 条
[21]   Cardiac hypertrophy: The good, the bad and the ugly [J].
Frey, N ;
Olson, EN .
ANNUAL REVIEW OF PHYSIOLOGY, 2003, 65 :45-79
[22]   Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress [J].
Frey, N ;
Barrientos, T ;
Shelton, JM ;
Frank, D ;
Rütten, H ;
Gehring, D ;
Kuhn, C ;
Lutz, M ;
Rothermel, B ;
Bassel-Duby, R ;
Richardson, JA ;
Katus, HA ;
Hill, JA ;
Olson, EN .
NATURE MEDICINE, 2004, 10 (12) :1336-1343
[23]  
Gautel M, 2008, ADV EXP MED BIOL, V642, P176
[24]   Sarcoplasmic reticulum Ca2+ leak in heart failure:: mere observation or functional relevance? [J].
George, Christopher H. .
CARDIOVASCULAR RESEARCH, 2008, 77 (02) :302-314
[25]   Regulation of cardiac hypertrophy by intracellular signalling pathways [J].
Heineke, Joerg ;
Molkentin, Jeffery D. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (08) :589-600
[26]  
Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573
[27]   CIB1 is a regulator of pathological cardiac hypertrophy [J].
Heineke, Joerg ;
Auger-Messier, Mannix ;
Correll, Robert N. ;
Xu, Jian ;
Benard, Matthew J. ;
Yuan, Weiping ;
Drexler, Helmut ;
Parise, Leslie V. ;
Molkentin, Jeffery D. .
NATURE MEDICINE, 2010, 16 (08) :872-U68
[28]   Modulation of β-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5 [J].
Ho, David ;
Yan, Lin ;
Iwatsubo, Kousaku ;
Vatner, Dorothy E. ;
Vatner, Stephen F. .
HEART FAILURE REVIEWS, 2010, 15 (05) :495-512
[29]  
Huang ZM, 2011, FRONT BIOSCI, V17, P3057
[30]   Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction - Results of the PREMIER (prevention of myocardial infarction early remodeling) trial [J].
Hudson, Michael P. ;
Armstrong, Paul W. ;
Ruzyllo, Witold ;
Brum, Jose ;
Cusmano, Lisa ;
Krzeski, Piotr ;
Lyon, Robert ;
Quinones, Miguel ;
Theroux, Pierre ;
Sydlowski, Diana ;
Kim, Henry E. ;
Garcia, Mario J. ;
Jaber, Wael A. ;
Weaver, W. Douglas .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) :15-20